MedPath
HSA Approval

PERIOCLINE PERIODONTAL OINTMENT 2% W/W

SIN15172P

PERIOCLINE PERIODONTAL OINTMENT 2% W/W

PERIOCLINE PERIODONTAL OINTMENT 2% W/W

February 3, 2017

SUNSTAR SINGAPORE PTE. LTD.

SUNSTAR SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNSTAR SINGAPORE PTE. LTD.
Licence HolderSUNSTAR SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

**DOSAGE AND ADMINISTRATION** Insert the tip of the applicator in periodontal pockets of each tooth as deeply as possible prior to injecting a sufficient amount of gel to fill the pockets. Approximately 25 mg of gel is administered into pockets of 5 to 7 mm in depth. The treatment starts with applications every 14 days, up to a total of 3 or 4 applications (over 4 to 6 weeks). Then the applications will be made every 3 months.

PERIODONTAL

Medical Information

**INDICATIONS** Periocline® is indicated for the treatment of severe chronic periodontitis in adults. It should be used as an adjunct to conventional scaling and root planing.

**CONTRAINDICATIONS** - Allergy to tetracycline antibiotics. - The use of this drug should be avoided for children less than 8 years of age due to the risk of permanent teeth discoloration and of dental enamel hypoplasia. - Pregnancy and lactation. - Use in association with retinoids.

A01AB23

minocycline

Manufacturer Information

SUNSTAR SINGAPORE PTE. LTD.

Sunstar Inc.

Active Ingredients

Minocycline hydrochloride 21.59mg/g eqv Minocycline

20mg/g

Minocycline

Documents

Package Inserts

PERIOCLINE_SGP PI.pdf

Approved: June 16, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.